In our former investigations, we found that IRTKS and Pinkbar (the other members of I-BAR domain-containing protein subfamily) may be considered as potential targets in cancer treatment using hAMSCs secretome [15, 16]. This evidence concerns the gene BAIAP2L1 and cancer.